Ferreira SG et al. |
N-acyldopamines control striatal input terminals via novel ligand-gated cation channels. |
2009 |
Neuropharmacology |
pmid:19101577
|
Hillard CJ and Jarrahian A |
Accumulation of anandamide: evidence for cellular diversity. |
2005 |
Neuropharmacology |
pmid:15910883
|
Umathe SN et al. |
Endocannabinoid analogues exacerbate marble-burying behavior in mice via TRPV1 receptor. |
2012 |
Neuropharmacology |
pmid:22248639
|
Price TJ et al. |
A role for the anandamide membrane transporter in TRPV1-mediated neurosecretion from trigeminal sensory neurons. |
2005 |
Neuropharmacology |
pmid:15992578
|
Gamber KM et al. |
Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus. |
2005 |
Neuropharmacology |
pmid:15949823
|
Schreiber AK et al. |
Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats. |
2012 |
Neuropharmacology |
pmid:22959964
|
Starowicz K et al. |
Spinal anandamide produces analgesia in neuropathic rats: possible CB(1)- and TRPV1-mediated mechanisms. |
2012 |
Neuropharmacology |
pmid:22178705
|
Sokal DM et al. |
Intraplantar injection of anandamide inhibits mechanically-evoked responses of spinal neurones via activation of CB2 receptors in anaesthetised rats. |
2003 |
Neuropharmacology |
pmid:12871657
|
Liu J et al. |
Multiple pathways involved in the biosynthesis of anandamide. |
2008 |
Neuropharmacology |
pmid:17631919
|
Guindon J and Beaulieu P |
Antihyperalgesic effects of local injections of anandamide, ibuprofen, rofecoxib and their combinations in a model of neuropathic pain. |
2006 |
Neuropharmacology |
pmid:16442133
|
Nader J et al. |
Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors. |
2014 |
Neuropharmacology |
pmid:24709540
|
Lisboa SF and Guimarães FS |
Differential role of CB1 and TRPV1 receptors on anandamide modulation of defensive responses induced by nitric oxide in the dorsolateral periaqueductal gray. |
2012 |
Neuropharmacology |
pmid:22394688
|
Moreira FA et al. |
Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray. |
2007 |
Neuropharmacology |
pmid:17156799
|
Moreira FA et al. |
Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. |
2008 |
Neuropharmacology |
pmid:17709120
|
Morena M et al. |
Emotional arousal state influences the ability of amygdalar endocannabinoid signaling to modulate anxiety. |
2016 |
Neuropharmacology |
pmid:27553121
|
Citraro R et al. |
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy. |
2013 |
Neuropharmacology |
pmid:23206503
|
Wise LE et al. |
Evaluation of fatty acid amides in the carrageenan-induced paw edema model. |
2008 |
Neuropharmacology |
pmid:17675189
|
Roberts LA et al. |
Methanandamide activation of a novel current in mouse trigeminal ganglion sensory neurons in vitro. |
2008 |
Neuropharmacology |
pmid:17631916
|
Rubio M et al. |
CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats. |
2008 |
Neuropharmacology |
pmid:18371990
|
Wang W et al. |
Enhancement of apamin-sensitive medium afterhyperpolarization current by anandamide and its role in excitability control in cultured hippocampal neurons. |
2011 |
Neuropharmacology |
pmid:21272594
|
Vela G et al. |
Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine. |
1995 |
Neuropharmacology |
pmid:7566503
|
Suplita RL et al. |
Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla. |
2005 |
Neuropharmacology |
pmid:16129456
|
Lisboa SF et al. |
Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anxiety-like behavior in rats. |
2013 |
Neuropharmacology |
pmid:23899460
|
Poling JS et al. |
Anandamide, an endogenous cannabinoid, inhibits Shaker-related voltage-gated K+ channels. |
1996 |
Neuropharmacology |
pmid:8938728
|
Suplita RL et al. |
Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia. |
2006 |
Neuropharmacology |
pmid:16316669
|
Desroches J et al. |
Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CBâ‚ and CBâ‚‚ receptors. |
2014 |
Neuropharmacology |
pmid:24148808
|
Clapper JR et al. |
The endocannabinoid system as a target for the treatment of cannabis dependence. |
2009 |
Neuropharmacology |
pmid:18691603
|
Wilkerson JL et al. |
The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice. |
2017 |
Neuropharmacology |
pmid:27890602
|
Piomelli D |
More surprises lying ahead. The endocannabinoids keep us guessing. |
2014 |
Neuropharmacology |
pmid:23954677
|
Placzek EA et al. |
Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown. |
2008 |
Neuropharmacology |
pmid:18760289
|
Scherma M et al. |
The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition. |
2008 |
Neuropharmacology |
pmid:17904589
|
Gyires K and Zádori Z |
[Analysis of central mechanisms involved in gastric mucosal integrity]. |
2008 |
Neuropsychopharmacol Hung |
pmid:18956615
|
Mahler SV et al. |
Endocannabinoid hedonic hotspot for sensory pleasure: anandamide in nucleus accumbens shell enhances 'liking' of a sweet reward. |
2007 |
Neuropsychopharmacology |
pmid:17406653
|
Izumi Y and Zorumski CF |
NMDA receptors, mGluR5, and endocannabinoids are involved in a cascade leading to hippocampal long-term depression. |
2012 |
Neuropsychopharmacology |
pmid:21993209
|
Gunduz-Cinar O et al. |
Fluoxetine Facilitates Fear Extinction Through Amygdala Endocannabinoids. |
2016 |
Neuropsychopharmacology |
pmid:26514583
|
Monteleone P et al. |
Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa. |
2005 |
Neuropsychopharmacology |
pmid:15841111
|
Giuffrida A et al. |
Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms. |
2004 |
Neuropsychopharmacology |
pmid:15354183
|
Morena M et al. |
Neurobiological Interactions Between Stress and the Endocannabinoid System. |
2016 |
Neuropsychopharmacology |
pmid:26068727
|
Centonze D et al. |
A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission. |
2004 |
Neuropsychopharmacology |
pmid:15100701
|
Pietrzak RH et al. |
Cannabinoid type 1 receptor availability in the amygdala mediates threat processing in trauma survivors. |
2014 |
Neuropsychopharmacology |
pmid:24820537
|
Dubreucq S et al. |
Genetic dissection of the role of cannabinoid type-1 receptors in the emotional consequences of repeated social stress in mice. |
2012 |
Neuropsychopharmacology |
pmid:22434220
|
Oleson EB et al. |
Cannabinoid receptor activation shifts temporally engendered patterns of dopamine release. |
2014 |
Neuropsychopharmacology |
pmid:24345819
|
Falenski KW et al. |
FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration. |
2010 |
Neuropsychopharmacology |
pmid:20357755
|
Varvel SA et al. |
Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task. |
2007 |
Neuropsychopharmacology |
pmid:17047668
|
Sarchielli P et al. |
Endocannabinoids in chronic migraine: CSF findings suggest a system failure. |
2007 |
Neuropsychopharmacology |
pmid:17119542
|
Bortolato M et al. |
Anxiolytic-like properties of the anandamide transport inhibitor AM404. |
2006 |
Neuropsychopharmacology |
pmid:16541083
|
Seillier A et al. |
Phencyclidine-induced social withdrawal results from deficient stimulation of cannabinoid CBâ‚ receptors: implications for schizophrenia. |
2013 |
Neuropsychopharmacology |
pmid:23563893
|
Fernandez-Espejo E et al. |
Experimental parkinsonism alters anandamide precursor synthesis, and functional deficits are improved by AM404: a modulator of endocannabinoid function. |
2004 |
Neuropsychopharmacology |
pmid:15010694
|
Hill MN et al. |
Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis. |
2009 |
Neuropsychopharmacology |
pmid:19710634
|
Stein EA et al. |
Selective effects of the endogenous cannabinoid arachidonylethanolamide (anandamide) on regional cerebral blood flow in the rat. |
1998 |
Neuropsychopharmacology |
pmid:9803424
|